Latest News

Newly published model of FSHD and a potential gene therapy to improve functional outcomes

Facioscapulohumeral muscular dystrophy (FSHD) is the most prevalent dominantly inherited muscular dystrophy in the world. To date, there are no pharmacologic treatments available for the more than 850,000 people affected worldwide.

Source link

Related posts

Study describes TBI caregiver QOL measurement system


On Twitter, praise for Scott Gottlieb is sprinkled with a few dissenting opinions


Gossamer Bio becomes 2019’s second biotech ‘unicorn’ to go public


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World